Comparative arrhythmia patterns among patients on tyrosine kinase inhibitors

被引：0
|
作者：
Chen Wei
Muhammad Fazal
Alexander Loh
Ridhima Kapoor
Sofia Elena Gomez
Shayena Shah
Albert J. Rogers
Sanjiv M. Narayan
Paul J. Wang
Ronald M. Witteles
Alexander C. Perino
Paul Cheng
June-Wha Rhee
Tina Baykaner
机构：
[1] Stanford University,Department of Internal Medicine
[2] Stanford University,Department of Cardiovascular Medicine
[3] Kaiser Permanente Santa Clara Homestead Medical Center,Department of Internal Medicine
[4] Stanford University,Stanford University School of Medicine
[5] City of Hope Comprehensive Medical Center,Division of Cardiology, Department of Medicine
来源：
Journal of Interventional Cardiac Electrophysiology | 2024年 / 67卷
关键词：
Cardio-oncology; Tyrosine kinase inhibitors; Ibrutinib; Arrhythmias; Atrial fibrillation; Tyrosine kinase inhibitors; Atrial arrhythmias; Ventricular arrhythmias;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：111 / 118
页数：7
相关论文
共 50 条
  • [31] Comparative assessment of the tyrosine kinase inhibitors dasatinib and bosutinib on CLL cells
    Kuckertz, M.
    Kerwien, S.
    Imam, H.
    Hallek, M.
    Krause, G.
    ONKOLOGIE, 2011, 34 : 140 - 141
  • [32] Comparative Cardiotoxicity of Tyrosine Kinase Inhibitors Ponatinib and PF114
    Singh, Anand P.
    Umbarkar, Prachi
    Glennon, Michael S.
    Zhang Qinkun
    Chilov, Ghermes
    Becker, Jason R.
    Lal, Hind
    CIRCULATION RESEARCH, 2019, 125
  • [33] Prescriber treatment patterns for tyrosine kinase inhibitors (TKI) and mammalian target of rapamycin (mTOR) inhibitors in patients with renal cell carcinoma
    Montgomery, Jim
    Garofalo, David
    Drenning, Jason
    Feinberg, Bruce A.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [34] Real-world (RW) treatment patterns and comparative effectiveness of Bruton tyrosine kinase inhibitors (BTKi) in patients (pts) with mantle cell lymphoma (MCL).
    Shah, Bijal D.
    Yang, Keri
    Klink, Andrew J.
    Liu, Tom
    Zimmerman, Todd M.
    Gajra, Ajeet
    Tang, Boxiong
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E18727 - E18727
  • [35] TYROSINE KINASE INHIBITORS AND THE TESTIS
    Gnessi, Lucio
    Mariani, Stefania
    Basciani, Sabrina
    ANDROLOGY, 2013, 1 : 34 - 34
  • [36] MET tyrosine kinase inhibitors
    不详
    NATURE REVIEWS DRUG DISCOVERY, 2008, 7 (06) : 469 - 469
  • [37] Novel tyrosine kinase inhibitors
    不详
    EXPERT OPINION ON THERAPEUTIC PATENTS, 1996, 6 (02) : 211 - 212
  • [38] Update on tyrosine kinase inhibitors
    Hidalgo, M
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S4 - S4
  • [39] Pharmacology of Tyrosine Kinase Inhibitors
    Hulin, Anne
    Gele, Thibaut
    Fenioux, Charlotte
    Kempf, Emmanuelle
    Sahali, Dil
    Tournigand, Christophe
    Ollero, Mario
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 19 (07): : 927 - 938
  • [40] Tyrosine Kinase Inhibitors and Interferon
    Dimou, Maria
    Panayiotidis, Panagiotis
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2014, 6 (01):
12345